About NuCana plc - American Depositary Shares (NCNA)
Nucana Plc is a biotechnology company focused on developing and commercializing innovative therapies for cancer treatment. The company utilizes its proprietary nucleoside chemistry platform to design and create next-generation nucleoside analogs that target various cancer types. Nucana aims to address the limitations of existing cancer therapies by developing treatments that can enhance efficacy and reduce toxicity, ultimately improving patient outcomes. Through its research and clinical trials, the company is dedicated to advancing new medicines that offer hope to patients battling challenging malignancies. Read More
In today’s fast-paced market, a bold group of under-$1 OTC and micro-cap stocks are attracting serious investor attention across sectors like oncology biotech, clean energy, digital health, critical minerals, and automation. These emerging companies are executing high-impact strategies, unveiling major milestones, and tapping into billion-dollar trends—all while trading under $1.
EDINBURGH, United Kingdom, July 11, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing twenty-five (25) ordinary shares, to one (1) ADS representing five thousand (5,000) ordinary shares (the "ADS Ratio"). The change in the ADS Ratio is expected to become effective on or about August 8, 2025 (the "Effective Date").
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Clifton Mining Company (OTC: CFTN) released a positive production update today, highlighting Desert Hawk Gold Corp.’s return to active mining operations and robust early results. As previously announced in April 2025, Desert Hawk resumed mining and has since sold over $500,000 worth of gold within the past month, marking a pivotal step forward in the project’s ramp-up phase.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
